JSC "Qazaqstan Investment Corporation" summed up the results of 2025

JSC Qazaqstan Investment Corporation (QIC, a subsidiary of JSC NIH Baiterek), has summarized its results for 2025, marking a transition to a multi-level capital management platform with a diversified investment portfolio and expanded international presence.

During the year, funds with QIC participation financed 15 new projects. The total number of implemented and supported projects exceeded 140, covering key sectors of the economy — from manufacturing and agribusiness to IT, infrastructure, and export-oriented industries.

One of the key achievements was the establishment of a new architecture for direct investment funds under the Astana International Financial Centre (AIFC) jurisdiction. In 2025, Kokzhiyek Fund L.P., with a target size of $4 billion, began active operations, focusing on large-scale investment projects in priority sectors of the economy. At the end of the year, Adal Fund L.P., with a target size of $1 billion, was registered to support export-oriented agribusiness and the consolidation of domestic agricultural producers.

During the reporting period, QIC completed six full and partial exits from projects totaling KZT 21.7 billion. These investments created over 4,900 jobs and generated KZT 10.5 billion in tax revenues. Key deals included exits from Aitas KZ and EMC Agro projects.

In 2025, QIC also strengthened its international investment presence by joining specialized funds such as Forebright Life Science Technology Fund LP and TVM Healthcare SEA Fund LP. In the venture segment, the corporation joined Sturgeon Emerging Opportunities II LP and the fund-of-funds Alem Ventures Fund LP with a target size of $1 billion.

The results of 2025 confirm Qazaqstan Investment Corporation’s transition into a scaling phase and reinforce its role as one of the key institutional investors driving the long-term development of Kazakhstan’s economy.

For reference:

Qazaqstan Investment Corporation JSC – is a private equity fund of funds established in 2007, whose primary mission is to promote Kazakhstan’s sustainable economic growth by attracting direct investments and supporting projects that contribute to the modernization and enhanced competitiveness of key industries. It is a subsidiary of Baiterek NIH JSC. See additional information on the website https://qic.kz/ru .